Keywords: Neurotransmission, Metabolism, Spectroscopy, Brain, Animal
Motivation: Recently FDA has approved S-ketamine for the treatment of drug-resistant depression. However, the impact of long-term use of ketamine on mood, cognition, and neurotransmitter pathways is not clear.
Goal(s): To assess the impacts of chronic ketamine administration on mood, cognition, and neurometabolism in the mice model.
Approach: 1H-[13C]-NMR spectroscopy in conjunction with an intravenous [1,6-13C2]glucose infusion was used for neurometabolic measurements.
Results: Ketamine administered mice showed hyperactivity, reduced cognition, and depression-like phenotypes. Moreover, chronic ketamine exposure increased the metabolic activity of glutamatergic and GABAergic neurons in the cerebral cortex.
Impact: Ketamine, a rapid-acting antidepressant, has been abused as a party drug historically. This study was performed to uncover the adverse effects of chronic ketamine administration and will be useful in designing better treatment approaches for depression.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords